NFE2L2 and Alzheimer disease: In an in vitro model of Alzheimer’s disease, the activation of NRF2-mediated antioxidant response and the consequent upregulation of system Xc− is involved in neuronal death due to increased glutamate release (D’Ezio et al., 2021).